TECHWIRE 30
(CIX: WRAL30)  1,195.53  down arrow-2.07  (-0.17 %)  Updated: 08:10 PM EDT, Jul 31 2015
(NQ: Apple)  121.30  down arrow-1.07  (-0.87 %)  Updated: 08:10 PM EDT, Jul 31 2015
(NY: QUINTILES)  76.72  down arrow-2.03  (-2.58 %)  Updated: 06:40 PM EDT, Jul 31 2015
(OP: BASF SE)  86.25  up arrow+1.37  (1.61 %)  Updated: 05:20 PM EDT, Jul 31 2015
(NQ: BioCryst)  15.48  up arrow+0.14  (0.91 %)  Updated: 08:10 PM EDT, Jul 31 2015
(NQ: BioDelivery)  8.15  up arrow+0.5  (6.54 %)  Updated: 08:10 PM EDT, Jul 31 2015
(NQ: CEMP)  41.86  up arrow+0.54  (1.31 %)  Updated: 08:10 PM EDT, Jul 31 2015
(NQ: Cisco Systems)  28.42  up arrow+0.12  (0.42 %)  Updated: 08:10 PM EDT, Jul 31 2015
(NQ: Cree)  24.65  down arrow-0.69  (-2.72 %)  Updated: 08:10 PM EDT, Jul 31 2015
(NQ: DARA)  0.82  down arrow-0.01  (-1.2 %)  Updated: 08:10 PM EDT, Jul 31 2015
(NY: EMC CORPORATION)  26.89  up arrow+0.11  (0.41 %)  Updated: 06:40 PM EDT, Jul 31 2015
(NQ: Extreme Networks)  2.32  down arrow-0.03  (-1.28 %)  Updated: 08:10 PM EDT, Jul 31 2015
(NQ: FB)  94.01  down arrow-1.2  (-1.26 %)  Updated: 08:10 PM EDT, Jul 31 2015
(NY: GLAXOSMITHKLINE)  43.44  down arrow-0.15  (-0.34 %)  Updated: 06:40 PM EDT, Jul 31 2015
(NQ: GOOG)  625.61  down arrow-6.98  (-1.1 %)  Updated: 08:10 PM EDT, Jul 31 2015
(NY: IBM)  161.99  up arrow+1.03  (0.64 %)  Updated: 06:40 PM EDT, Jul 31 2015
(NY: LH)  127.29  up arrow+1.67  (1.33 %)  Updated: 06:40 PM EDT, Jul 31 2015
(OP: Lenovo Group)  21.60  down arrow-0.7  (-3.14 %)  Updated: 05:20 PM EDT, Jul 31 2015
(NY: MRK)  58.96  up arrow+0.44  (0.75 %)  Updated: 06:40 PM EDT, Jul 31 2015
(NQ: Microsoft Corp)  46.70  down arrow-0.18  (-0.38 %)  Updated: 08:10 PM EDT, Jul 31 2015
(NQ: NTAP)  31.15  down arrow-0.42  (-1.33 %)  Updated: 08:10 PM EDT, Jul 31 2015
(NY: NOVARTIS AG)  103.75  up arrow+0.57  (0.55 %)  Updated: 06:40 PM EDT, Jul 31 2015
(OP: Novozymes A/S)  52.33  up arrow+0.71  (1.38 %)  Updated: 05:20 PM EDT, Jul 31 2015
(NY: PFIZER)  36.06  up arrow+0.33  (0.92 %)  Updated: 06:40 PM EDT, Jul 31 2015
(NQ: Pozen)  11.60  up arrow+0.1  (0.87 %)  Updated: 08:10 PM EDT, Jul 31 2015
(NY: RED HAT)  79.08  down arrow-0.37  (-0.47 %)  Updated: 06:40 PM EDT, Jul 31 2015
(NQ: BBRY)  7.74  down arrow-0.19  (-2.34 %)  Updated: 08:10 PM EDT, Jul 31 2015
(NQ: Salix)  172.81    (0 %)  Updated: 08:10 PM EDT, Apr 01 2015
(NQ: SQI)  11.89  down arrow-1.75  (-12.83 %)  Updated: 08:10 PM EDT, Jul 31 2015

Posts tagged “Biotech & Life Science”

8:42 a.m. Friday

Good times, hard times ... Biogen celebrates 20 years in Research Triangle Park

There were jokes. There were fond reminiscences. There were stories about hard times endured and challenges overcome. But most of all, there were testaments of great pride and appreciation from the leaders who shaped, nurtured and built Biogen's giant Research Triangle Park biomanufacturing campus into one of the world's leading biotechnology manufacturing sites.

Remembering 20 years of Biogen in RTP Remembering 20 years of Biogen in RTP

Updated 6:25 a.m. Friday

vTv Therapeutics goes public, raising $117M - then shares collapse

vTv Therapeutics, which is focused on development of a treatment for Alzheimer's, went public on the Nasdaq on Thursday. The company raised more than $117 million, selling nearly 8 million shares. However, share value collapsed during the day, plummeting 28 percent.

vtV goes public vtV goes public

2:25 p.m. Wednesday

Premium Lock Is GSK open to a merger? 'A big issue to cross,' CEO says

In a conference call, GlaxoSmithKline's top executive is asked if he would consider "pairing up" with another drug company. Back in May, an analyst started talk of a "PfizerKline" merger. GSK's CEO Andrew Witty notes a merger would be a "big issue to cross."

Andrew Witty      Andrew Witty

11:31 a.m. Wednesday

Ex-GSK employees facing layoffs at Parexel; firm won't comment

Layoffs        As many as 200 former GlaxoSmithKline employees who were transferred to life science services firm Parexel earlier this year are reportedly being laid off today. However, the Boston-based company which has a large presence in the Triangle, isn't talking.

8:28 a.m. Wednesday

GSK shares climb 3% after better-than-expected earnings

GSK's HQ in London            Shares in drug giant GlaxoSmithKline surged 3 percent early Wednesday after the company reported a better-than-expected decline in earnings. CEO Andrew Witty says the results are "encouraging."

Updated 7:50 a.m. Wednesday

Newborn health screening firm nabs $13M

Durham-based Baebies, a health-screening startup, has raised $13 million in equity financing, the company said Monday. Backers include Rex Health Ventures, Duke Angel Network, Duke University's DUMAC, and the NC Biotechnology Center.

Updated 7:30 a.m. Wednesday

Quintiles beats Street expectations despite impact of stronger dollar

Quintiles            Quintiles beats Wall Street analysts' expectations for revenue and earnings in the second quarter despite the impact of a stronger dollar on its overseas business. Will its stock rally on the news?

11:09 a.m. Tuesday

Premium Lock Cary-based Plasma solutions firm seeks $1.5M

Atmospheric Plasma Solutions, a Cary-based company with strategic ties to North Carolina State University is seeking $1.5 million in equity, according to a regulatory filing. It uses plasma technology to enable a wide range of materials processing options that may otherwise be out of reach, such as a process that previously required costly and dangerous chemicals or high temperatures.

Atmospheric Plasma Solutions coating removal. Atmospheric Plasma Solutions coating removal.

2:37 p.m. Monday

Software turns smartphones into medical research tools

 Jody Kearns doesn't like to spend time obsessing about her Parkinson's disease. The 56-year-old dietitian from Syracuse, New York, had to give up bicycling because the disorder affected her balance. But she still works, drives and tries to live a normal life.

Updated July 24

Biogen stock plunges 15 percent on lowered guidance

New sign at Biogen's RTP campus Cambridge, MA-based Biogen Inc., saw its stock price fall after slashing its guidance outlook for the rest of the year in its second quarter earnings report. The company also said it received FDA approval to make its multiple schlerosis drug at its Durham plant.

July 24

VBX CEO on "Buzz of Bio" pitch to global hitters

David Mann, CEO, Vascular Biosciences As the CEO of Vascular Biosciences (VBS), I was very excited to be notified by the Biotechnology Innovation Organization (BIO) that our company was the 2015 "Buzz of BIO" award winner in the "Pipelines of Promise" category.

July 23

RTP drug firm Scynexis moving to New Jersey, sells service business

Scynexis Scynexis, a drug firm whose most promising product is an anti-fungal treatment, is selling its service business and relocating to New Jersey. The company's founder also is stepping down as president.

July 23

Triangle jumps to No. 2 in life science hub rankings

Biotech & Life Science North Carolina's Raleigh-Durham region, a.k.a. the Research Triangle, has the nation's second leading life science base among major metro areas, up from No. 4 since last year, according to a new report.

July 21

NC Biotech Center awards $1.8M in loans, grants across state

N.C. Biotech Center    The numbers are in for the most recent quarter and the end of fiscal 2015: The N.C. Biotechnology Center reports awarding $1.8 million in grants and loans for the most recent quarter, adding up to nearly $6.8 million for the year.

July 21

In her own words: Mary-Dell Chilton's path to greatness, and her call to action

Dr. Mary-Dell Chilton hasn't yet won a Nobel Prize. Yet. But her trophy case is already full of bioscience biggies. This year, for example, she was finally inducted into the National Inventors Hall of Fame. And she was made a World Food Prize laureate in 2013. In 2002 she received the Benjamin Franklin Medal from the Franklin Institute in Philadelphia, joining a roster of winners including Alexander Graham Bell, Thomas Edison, Pierre and Marie Curie, Albert Einstein and Stephen Hawking. In a talk at the NC Biotechnology Center, she recounts her career and the opportunities she sees in the future for plant science - "the best of times and the worst of times."

Dr. Mary-Dell Chilton Dr. Mary-Dell Chilton

July 21

Hawking looks for ET; cheating website hacked; strut doomed SpaceX rocket; Novartis earnings

Bulldog In today's Bulldog wrapup of technology and life science news: Stephen Hawking goes looking for ET; cheating website Ashley Madison is hacked; SpaceX says a strut failure doomed a rocket; and a strong dollar hurts Novartis.

Updated July 20

Innovate Raleigh, Patriot Boot Camp highlight regional tech calendar

Social networking The countdown is nearing zero for the fourth annual Innovate Raleigh Summit. Plus, High-tech accelerator Techstars is bringing its program to help veterans who want to become entrepreneurs - called Patriot Boot Camp - to Chapel Hill. Plus, other tech events.

July 20

WTW news in review: Week of July 12 (Part 1)

Week in review Here's a look back at technology, life science and other related news as reported in WRAL TechWire for the week of July 12, part one.

July 20

WTW news in review: Week of July 12 (Part 2)

Week in Review Here's a look back at technology, life science and other related news as reported in WRAL TechWire the week of July 12, part two.

July 20

WTW news in review: Week of July 5 (Part 1)

Week in review Here's a look back at technology, life science and other related news as reported in WRAL TechWire for the week of July 5, part one.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith